The effects of piracetam on cognitive performance in a mouse model of Down's syndrome (Q44207240)

30 November 2017

The effects of piracetam on cognitive performance in a mouse model of Down's syndrome (English)

1 reference

30 November 2017

4

Muriel T Davisson

1 reference

30 November 2017

Timothy H Moran

1

1 reference

30 November 2017

George T Capone

2

1 reference

30 November 2017

Susan Knipp

3

1 reference

30 November 2017

Roger H Reeves

5

1 reference

30 November 2017

John D Gearhart

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

Physiology & Behavior

1 reference

30 November 2017

77

1 reference

30 November 2017

2-3

1 reference

30 November 2017

403-409

1 reference

Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Effects of piracetam on the performance of rats in a delayed match-to-position task.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Motor dysfunction in a mouse model for Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Long-term and high-dose piracetam treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Spatial memory deficits in segmental trisomic Ts65Dn mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Enhancement of hippocampally-mediated learning and protein kinase C activity by oxiracetam in learning-impaired DBA/2 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Piracetam therapy does not enhance cognitive functioning in children with down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Place navigation impaired in rats with hippocampal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

A mouse model for Down syndrome exhibits learning and behaviour deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Effects of piracetam on indices of cognitive function in a delayed alternation task in young and aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Effect of chronic piracetam on age-related changes of cross-maze exploration in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Pyrrolidone derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

Piracetam diminishes hippocampal acetylcholine levels in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900873-9

7 January 2021

10.1016/S0031-9384(02)00873-9

Identifiers

DOI

1 reference

30 November 2017

1 reference